Programming & Reprogramming I: SRs in Health and Disease States

Go Back

Dr. Jennifer Richer, Professor with tenure, Department of Pathology, University of Colorado Anschutz Medical Campus, has studied steroid hormone receptor action in breast for over 25 years. Translational studies from her lab led to two completed clinical trials targeting the androgen receptor in primary and metastatic breast cancer. The Richer lab also discovered a mechanism by which carcinomas c